Breaking News

Pfizer Inc (PFE)

Symbol	Exchange	Currency
PFE	NYSE	USD	Real-time
PFE	CBOE Canada	CAD	Real-time
PFE	Mexico	MXN	Delayed
1PFE	Milan	EUR	Real-time
PFE	Hamburg	EUR	Delayed
PFE	Xetra	EUR	Delayed
PFE	TradeGate	EUR	Delayed
PFE	Frankfurt	EUR	Delayed
PFE	Santiago	USD	Delayed
PFEm	Buenos Aires	ARS	Delayed
PFIZ34	B3	BRL	Delayed
PFE	Vienna	EUR	Real-time
PFE	Ukraine	UAH	Delayed
PFE_KZTQBD	KASE	USD	Delayed
PFE_KZ	KASE	USD	Delayed
PFE	Colombia	COP	Delayed
PFE	Lima	USD	Delayed

Add to/Remove from Watchlist Add to Watchlist

22.26 -0.00 0.00%

16/04 - Closed. Currency in USD

Type: Equity

Market: Peru

ISIN: US7170811035

S/N: PFE

Volume: 2
Bid/Ask: 0.00 / 0.00
Day's Range: 22.15 - 22.26

General
Chart
- Streaming Chart
- Interactive Chart
News & Analysis
- News
- Analysis & Opinion
Financials
Technical
- Technical Analysis
- Analyst Price Target
Forum

Pfizer Inc Company Profile

Get an in-depth profile of Pfizer Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.

IndustryPharmaceuticals

SectorHealthcare

Employees

81000

Equity Type

ORD

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Octagam, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Contact Information

Address 66 Hudson Boulevard East
New York, 10001-2192
United States

Phone 212 733 2323

Fax -

Web www.pfizer.com

Top Executives

Name	Age	Since	Title
Charles T. Hagel	77	-	Member of Emerging Markets Advisory Board
Shantanu Narayen	59	2013	Lead Independent Director
Albert Bourla	61	2016	Chairman of the Board & CEO
Joseph J. Echevarria	66	2015	Independent Director
Helen H. Hobbs	71	2011	Independent Director
Suzanne M. Nora Johnson	66	2007	Independent Director
James C. Smith	63	2014	Independent Director
Daniel R. Littman	70	2018	Independent Director
Susan Desmond-Hellmann	66	2020	Independent Director
Scott Gottlieb	50	2019	Independent Director
James Robert B. Quincey	58	2020	Independent Director
Ronald E. Blaylock	63	2017	Independent Director
Susan J. Hockfield	71	2020	Independent Director
Mortimer Joseph Buckley	55	2024	Independent Director
Cyrus Russi Jal Taraporevala	58	2024	Independent Director

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.
Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read Investing.com's comments guidelines and agree to the terms described.

I Agree

PFE Comments

Write your thoughts about Pfizer Inc

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

shortseller Best 12 hours ago

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Pfizer's stock price will never go up unless the CEO steps down.

2 0

Report

Stephen Bailey Apr 16, 2025 12:00PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

At these levels and with dollar weakness this is becoming increasingly attractive to an overseas aquirer that would instantly gain a US manufacturing base. I currently have no position

6 0

Report

WallWolf Apr 16, 2025 9:51AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

is this Trumps new executive order good for pharma companies or not??

0 0

Report

Shah King Apr 15, 2025 10:03AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

don't know why is going up despite the negative news on its oral weight loss drug

1 0

Report

Shah King Apr 14, 2025 9:32AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

sell the news buy the dips

1 0

Report

Bill Oskouee Apr 13, 2025 10:30PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

I can’t believe why this stock with 7% Dividend is at 22, something going on Management can not run this company They should leave and replace with qualified management

0 0

Report

shortseller Best Apr 13, 2025 8:31AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

A good dividend means a bad stock price. Investment is not recommended.

1 1

Report

Michael So Apr 13, 2025 8:31AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

It may be a value trap - price target downgrades - management needs to urgently reassess.

0 1

Report

Jindrich Ruzek Apr 11, 2025 7:11AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Don't watch and hold. Good dividend

2 0

Report

Michael So Apr 10, 2025 2:30PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Dear all, after years having the stock at the watch list I am happy to tell you that I bought the stock today for the first time at $ 21,28!

6 0

Report

Hung Tran Apr 10, 2025 2:30PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Me too

1 0

Report

Bill Oskouee Apr 09, 2025 11:36PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Management cant run this company Why this should be $22 at 20 year low If they cant run this company they should step down, share holders are paying the price for all the bad acquisitions

1 0

Report

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="247921685">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="247921685" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="247921685" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="247921685">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="210629920">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="210629920" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="210629920" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d1-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="210629920">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

US 30	38,144.1	-26.3	-0.07%
US 500	5,152.0	-6.2	-0.12%
Dow Jones	38,170.41	-971.82	-2.48%
S&P 500	5,158.20	-124.50	-2.36%
Nasdaq	15,870.90	-415.55	-2.55%
S&P 500 VIX	33.84	+4.19	+14.13%
Dollar Index	98.04	-1.09	-1.10%

Crude Oil WTI	62.87	+0.46	+0.74%
Brent Oil	66.47	-1.49	-2.19%
Natural Gas	3.040	-0.013	-0.43%
Gold	3,449.81	+24.51	+0.72%
Silver	32.708	+0.187	+0.57%
Copper	4.7383	+0.0178	+0.38%
US Soybeans	1,029.50	0.00	0.00%

U.S. 10Y	4.401	-0.004	-0.09%
U.S. 30Y	4.908	-0.003	-0.06%
U.S. 5Y	3.980	+0.021	+0.53%
U.S. 3M	4.330	+0.008	+0.19%
US 10Y T-Note	110.78	-0.03	-0.03%
Euro Bund	131.49	0.00	0.00%
10-2 Yield Spread	31.32	+4.15	+15.27%

Apple	193.09	-3.89	-1.97%
NVIDIA	96.91	-4.58	-4.51%
Alphabet A	147.66	-3.50	-2.32%
Tesla	227.46	-13.91	-5.76%
Amazon.com	167.27	-5.34	-3.09%
Netflix	987.91	+14.88	+1.53%
Meta Platforms	484.48	-17.00	-3.39%

Recent Quotes

	Name	Price	Chg.	Chg. %
	PFE	22.26	-0.00	0.00%

Market Movers

Name	Last	Chg. %	Vol.
NVDA	96.91	-4.51%	270.92M
TSLA	227.46	-5.76%	84.04M
PLTR	90.80	-3.18%	82.87M
AMZN	167.27	-3.09%	45.11M
AAPL	193.09	-1.97%	32.80M
META	484.48	-3.39%	13.39M
NFLX	987.91	+1.53%	9.65M

Name	Last	Chg. %	Vol.
DFS	165.31	+3.56%	4.43M
DG	95.61	+2.73%	4.59M
FIS	76.40	+2.44%	10.25M
MCHP	39.42	+2.23%	13.35M
ULTA	365.58	+2.19%	734.85K
WST	205.88	+1.97%	898.13K
MRNA	25.13	+1.68%	6.82M

Name	Last	Chg. %	Vol.
UHS	157.05	-10.15%	1.25M
BX	120.22	-7.80%	6.66M
VST	106.52	-7.71%	5.94M
HUM	245.91	-7.02%	2.03M
CEG	192.61	-6.81%	3.27M
EQT	47.67	-6.49%	6.83M
UNH	425.33	-6.34%	12.95M

Webinars

From Beginner to Pro: Navigating Your InvestingPro Subscription - April 23rd Wednesday, April 23, 2025 | 10:00AM EDT